ES2151572T3 - Benzoilguanidinas sustituidas con trifluoropropilo y su empleo como medicamento o agente de diagnostico. - Google Patents

Benzoilguanidinas sustituidas con trifluoropropilo y su empleo como medicamento o agente de diagnostico.

Info

Publication number
ES2151572T3
ES2151572T3 ES95113846T ES95113846T ES2151572T3 ES 2151572 T3 ES2151572 T3 ES 2151572T3 ES 95113846 T ES95113846 T ES 95113846T ES 95113846 T ES95113846 T ES 95113846T ES 2151572 T3 ES2151572 T3 ES 2151572T3
Authority
ES
Spain
Prior art keywords
trifluoropropilo
benzoilguanidinas
employment
medicinal
replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95113846T
Other languages
English (en)
Inventor
Andreas Dr Weichert
Heinz-Werner Dr Kleemann
Hans-Jochen Dr Lang
Jan-Robert Dr Schwark
Udo Dr Albus
Wolfgang Dr Scholz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2151572T3 publication Critical patent/ES2151572T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE DESCRIBEN BENZOILGUANIDINAS DE LA FORMULA I CON LAS DEFINICIONES DE R(1) HASTA R(4) DADAS EN EL TEXTO ASI COMO SUS SALES TOLERABLES FISIOLOGICAMENTE. SE OBTIENEN MEDIANTE TRANSFORMACION DE UN COMPUESTO II CON GUANIDINA. SON AGENTES SOBRESALIENTES PARA TRATAMIENTO DE ENFERMEDADES DEL SISTEMA DEL CICLO CARDIACO.
ES95113846T 1994-09-09 1995-09-04 Benzoilguanidinas sustituidas con trifluoropropilo y su empleo como medicamento o agente de diagnostico. Expired - Lifetime ES2151572T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4432105A DE4432105A1 (de) 1994-09-09 1994-09-09 Fluoro-alkyl/alkenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
ES2151572T3 true ES2151572T3 (es) 2001-01-01

Family

ID=6527787

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95113846T Expired - Lifetime ES2151572T3 (es) 1994-09-09 1995-09-04 Benzoilguanidinas sustituidas con trifluoropropilo y su empleo como medicamento o agente de diagnostico.

Country Status (24)

Country Link
US (2) US5869531A (es)
EP (1) EP0702001B1 (es)
JP (1) JPH0899950A (es)
KR (1) KR960010620A (es)
CN (1) CN1063436C (es)
AT (1) ATE195725T1 (es)
AU (1) AU698629B2 (es)
CA (1) CA2157856C (es)
CZ (1) CZ290027B6 (es)
DE (2) DE4432105A1 (es)
DK (1) DK0702001T3 (es)
ES (1) ES2151572T3 (es)
FI (1) FI954191A7 (es)
GR (1) GR3034512T3 (es)
HU (1) HU221851B1 (es)
IL (1) IL115194A (es)
NO (2) NO305117B1 (es)
NZ (1) NZ272948A (es)
PL (1) PL181206B1 (es)
PT (1) PT702001E (es)
RU (1) RU2159762C2 (es)
SI (1) SI9500281B (es)
TW (1) TW382621B (es)
ZA (1) ZA957549B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19540995A1 (de) * 1995-11-03 1997-05-07 Hoechst Ag Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PL316439A1 (en) * 1995-11-20 1997-05-26 Hoechst Ag Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
JP4745432B2 (ja) * 2009-09-30 2011-08-10 住友大阪セメント株式会社 光導波路素子
KR102825404B1 (ko) * 2021-11-11 2025-06-27 주식회사 엘지화학 화합물, 이의 제조 방법, 상기 화합물로 유래되는 단분자 및 중합체

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DK0556674T3 (da) * 1992-02-15 1996-10-14 Hoechst Ag 3,5-Substituerede benzoylguanidiner med antiarytmisk virkning og inhiberende virkning på celleproliferation
EP0556673B1 (de) * 1992-02-15 1997-09-17 Hoechst Aktiengesellschaft Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
DE4237035A1 (de) * 1992-11-03 1994-05-05 Vorwerk Co Interholding Staubfilterbeutel für einen Staubsauger
TW250477B (es) * 1992-12-15 1995-07-01 Hoechst Ag
EP0604852A1 (de) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters
DK0612723T3 (da) * 1993-02-20 1998-03-30 Hoechst Ag Substituerede benzoylguanidiner, fremgangsmåde til fremstilling, deres anvendelse som lægemiddel, som inhibitor af den cellulære Na+/H+-udbytning eller som diagnostikum samt lægemiddel med indhold deraf

Also Published As

Publication number Publication date
CZ231695A3 (en) 1996-03-13
NO953554D0 (no) 1995-09-08
FI954191L (fi) 1996-03-10
PL181206B1 (pl) 2001-06-29
NO305117B1 (no) 1999-04-06
CA2157856C (en) 2007-11-13
SI9500281B (en) 2001-12-31
IL115194A (en) 2003-01-12
CN1128752A (zh) 1996-08-14
US5998481A (en) 1999-12-07
IL115194A0 (en) 1995-12-31
NZ272948A (en) 1996-07-26
ATE195725T1 (de) 2000-09-15
DK0702001T3 (da) 2000-10-16
GR3034512T3 (en) 2000-12-29
CN1063436C (zh) 2001-03-21
AU698629B2 (en) 1998-11-05
HU9502633D0 (en) 1995-11-28
EP0702001A1 (de) 1996-03-20
PT702001E (pt) 2001-01-31
NO985244L (no) 1996-03-11
CA2157856A1 (en) 1996-03-10
CZ290027B6 (cs) 2002-05-15
ZA957549B (en) 1996-04-17
FI954191A7 (fi) 1996-03-10
US5869531A (en) 1999-02-09
KR960010620A (ko) 1996-04-20
AU3050595A (en) 1996-03-21
DE59508654D1 (de) 2000-09-28
FI954191A0 (fi) 1995-09-07
PL310345A1 (en) 1996-03-18
SI9500281A (en) 1996-04-30
EP0702001B1 (de) 2000-08-23
HU221851B1 (hu) 2003-02-28
TW382621B (en) 2000-02-21
NO985244D0 (no) 1998-11-10
NO306293B1 (no) 1999-10-18
DE4432105A1 (de) 1996-03-14
RU2159762C2 (ru) 2000-11-27
JPH0899950A (ja) 1996-04-16
NO953554L (no) 1996-03-11
HUT72652A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
ES2187575T3 (es) Hexapeptidos ciclicos dotados de actividad antibiotica.
ES2170141T3 (es) 4-aminoderivados del acido micofenolico con actividad inmunosupresora.
AR008305A1 (es) Guanidinas de acidos alquenil-carboxilicos sustituidos con fenilo, procedimientos para su preparacion, su utilizacion como medicamento o agente dediagnostico, asi como un medicamento que las contiene
AR003427A1 (es) Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas.
CO4290424A1 (es) Pirazolopiridinas, pirrolopiridinas, composiciones farmaceu- ticas que las contienen y procedimientos para su administra- cion como antagonista del factor de liberacion de cortico- tropina
PA8432901A1 (es) Compuestos de piridilpirrol
UY26332A1 (es) Nuevos derivados del ácido aminodicarboxílico con propiedades farmacéuticas.
ES2178779T3 (es) Nuevas amidas de acidos de piridil alcanos como agentes citoestaticos e inmunosupresores.
ES475854A1 (es) Un procedimiento para preparar derivados de glicosido de pleuromutilina
BRPI0408236A (pt) método para radiofluoração, composto, composição radiofarmacêutica, uso de um composto, e, métodos para gerar uma imagem de um corpo humano ou animal e para monitorar o efeito de tratamento de um corpo humano ou animal com um medicamento para combater uma condição associada com cáncer
ES2072323T3 (es) Compuestos de piperidina y su preparacion y empleo.
ES8504140A1 (es) Procedimiento para la preparacion de nuevos bencimidazoles substituidos
ES2066120T3 (es) Uso de derivados de bencimidazol como agentes antibacterianos.
ES2168359T3 (es) Acido micofenolico 6-sustituido y derivados con actividad inmunosupresora.
AR030947A1 (es) Guanidinas de acido cinamico substituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico asi como un medicamento que las contiene
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2192839T3 (es) Timosina beta 4 oxidada.
ES2135429T3 (es) Derivados de ciclohexano sustituidos para el tratamiento de enfermedades.
ES2147629T3 (es) Guanidinas de acido alquenilcarboxilico sustituidas con un grupo fluorofenilo como inhibidores del intercambio de na+/nh+, su procedimiento de preparacion y su uso como medicamento o agente diagnostico asi como el medicamento que las contiene.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
AR001073A1 (es) Benzoilguanidinas basicamente sustituidas procedimientos para su preparación su empleo como medicamento o agente de diagnostico asi como medicamento que las contiene
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
ES2151572T3 (es) Benzoilguanidinas sustituidas con trifluoropropilo y su empleo como medicamento o agente de diagnostico.
ES2149403T3 (es) Benciloxicarbonilguanidinas sustituidas como inhibidores del intercambiador de protones de sodio, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.
AR004004A1 (es) Benzoilguanidinas sustituida, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento quelas contiene.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 702001

Country of ref document: ES